Transaction DateRecipientSharesTypePriceValue
20th November 2020Daniel Horwood200Grant/award etc.$5.43$1,086.30
20th November 2020Andrew C. Jackson200Grant/award etc.$5.43$1,086.30
20th November 2020Jeffrey J Kraws200Grant/award etc.$5.43$1,086.30
19th November 2020William R Enquist5,263Open or private purchase$5.82$30,621.71
19th November 2020Martin J Colombatto8,700Open or private purchase$5.78$50,279.04
19th November 2020Richard Jr Mejia1,000Open or private purchase$5.82$5,820.00
19th November 2020Joan Stafslien4,410Open or private purchase$5.67$25,002.50
17th November 2020Jonathan Will Mc Guire104,254Grant/award etc.$0.00
17th November 2020Daniel Horwood19,591Grant/award etc.$0.00
12th October 2020Richard Jr Mejia100,000Grant/award etc.$0.00
Ra Medical Systems
Ra Medical Systems logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. It operates through the Dermatology and Vascular business segments.


Ticker: RMED
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1716621
Employees: 79
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals